Laplace Interventional

medical devices

About

Laplace Interventional is a medical device company located in Plymouth, Minnesota. The company focuses on developing a transcatheter tricuspid valve replacement (TTVR) system aimed at treating patients with Tricuspid Regurgitation (TR). This innovative device is designed to be delivered through a minimally invasive, percutaneous procedure, eliminating the need for open-heart surgery. The goal is to enhance patient outcomes and quality of life. Currently, the TTVR system is for investigational use only and is not available for commercial sale. Laplace Interventional has conducted an Early Feasibility Study (EFS) that has enrolled over 40 patients, showing promising results such as rapid patient discharge and positive clinical outcomes. Recently, the company completed a $22 million Series C financing round to support ongoing clinical studies and progress toward pivotal study approval.

Technologies

Outlook Microsoft Office 365 Amazon AWS Mobile Friendly Vimeo ADP

Keywords

medical equipment manufacturing clinical research heart valve procedure heart valve disease quality of life enhancement transcatheter tricuspid valve replacement life expectancy improvement healthcare equipment & supplies heart valve technology development heart valve technology heart valve repair tr treatment heart valve therapy heart valve transcatheter valve clinical feasibility minimally invasive surgery minimally invasive heart surgery heart valve intervention heart valve clinical trials cardiology cardiology innovation heart valve research heart valve implant percutaneous procedure heart disease treatment medical devices heart valve innovation percutaneous valve delivery device development

Location

12975 16th Ave N, Plymouth, Minnesota, United States, 55441-4549

Related Companies

Companies in the same industry